Kumar, R., Corbett, M. A., Van Bon, B. W., Gardner, A., Woenig, J. A., Jolly, L. A., Douglas, E., Friend, K., Tan, C., Van
Esch, H., Holvoet, M., Raynaud, M., Field, M., Leffler, M., Budny, B., Wisniewska, M., Badura-Stronka, M., Latos-Bielenska,
A., Batanian, J., Rosenfeld, J. A., Basel-Vanagaite, L., Jensen, C., Bienek, M., Froyen, G., Ullmann, R., Hu, H., Love, M.
I., Haas, S. A., Stankiewicz, P., Cheung, S. W., Baxendale, A., Nicholl, J., Thompson, E. M., Haan, E., Kalscheuer, V. M.,
& Gecz, J. (2015). Increased STAG2 dosage defines a novel cohesinopathy with intellectual
disability and behavioral problems. Human Molecular Genetics, 24(25),
7171-7181. doi:10.1093/hmg/ddv414.